Chenghui Yan

Title: Chenghui Yan: Innovator in Medical Applications of CREG Protein

Introduction

Chenghui Yan is a notable inventor based in Shenyang, China. He has made significant contributions to the field of medicine, particularly through his innovative research and patents. His work focuses on the medical applications of the CREG protein, which has potential implications for treating various heart conditions.

Latest Patents

Chenghui Yan holds a patent related to the medical use of Cellular Repressor of E1A-stimulated Genes (CREG). This invention pertains to the use of CREG protein or its active fragments in the manufacture of medicaments aimed at preventing and treating myocardial infarction. Additionally, it addresses ventricular remodeling after myocardial infarction and heart failure, as well as myocardial ischemia-reperfusion injury and salt-sensitive hypertensive myocardial fibrosis. This patent highlights the therapeutic potential of CREG in cardiovascular health.

Career Highlights

Chenghui Yan is affiliated with the General Hospital of Chinese PLA Northern Theater Command. His role in this esteemed institution allows him to engage in cutting-edge research and collaborate with other professionals in the medical field. His dedication to advancing medical science is evident through his innovative work and contributions.

Collaborations

Chenghui Yan has worked alongside notable colleagues, including Yaling Han and Xiaoxiang Tian. Their collaborative efforts contribute to the advancement of research in the medical applications of proteins and their potential benefits in treating heart-related conditions.

Conclusion

Chenghui Yan's contributions to the medical field through his patent on CREG protein exemplify the importance of innovation in healthcare. His work not only enhances our understanding of cardiovascular diseases but also paves the way for new treatment options.